Biotech · Private company
ImStem Biotechnology
Track this companyFree. Adds ImStem Biotechnology to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- IMS001Phase 1 · Multiple SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple SclerosisPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 31, 2021ClinicalTrials.gov NCT04956744 · fetched Nov 12, 2026